ICON Strengthens Its Leadership Team in Asia Pacific with Two Key Appointments
DUBLIN, Nov. 5, 2015 /PRNewswire/ -- ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced two new leadership appointments to itsAsia Pacific operations. Mary Pan has been appointe...
ICON and IBM to Revolutionise Clinical Trial Feasibility, Patient Recruitment and Study Start-up Timelines
DUBLIN, Sept. 14, 2015 /PRNewswire/ -- ICON plc, (NASDAQ: ICLR) a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical device industries, today announced that it is working with IBM (NYSE: IBM) to help reduce the time and costs of drug develo...